Skip to main content
. 2012 Mar 6;17(2):71–78. doi: 10.1016/j.rpor.2012.01.002

Table 2.

Results of multivariate analysis for various endpoints.

Endpoint Independent prognostic factor(s) p-Value HR (95% CI)
LRC Histology: WHO type II vs. III 0.02 2.86 (1.16–7.14)
DFFS N stage: N0 vs. N+ 0.045 0.28 (0.08–0.97)
DFS Age: ≤55 years vs. >55 years 0.027 0.46 (0.23–0.92)
EQD2,T: <64 Gy vs. ≥64 Gy 0.037 2.08 (1.04–4.17)
OS Age (years): ≤ 55 vs. >55 0.001 0.39 (0.23–0.68)

LRC, loco-regional control; DFFS, distant failure-free survival; DFS, disease-free survival; OS, overall survival; EQD2,T, equivalent tumor dose; HR, hazard ratio; CI, confidence interval.